Transition of early-phase treatment for acute pancreatitis: An analysis of nationwide epidemiological survey

World Journal of Gastroenterology : WJG
Shin HamadaTooru Shimosegawa

Abstract

Treatment of acute pancreatitis (AP) is one of the critical challenges to the field of gastroenterology because of its high mortality rate and high medical costs associated with the treatment of severe cases. Early-phase treatments for AP have been optimized in Japan, and clinical guidelines have been provided. However, changes in early-phase treatments and the relationship between treatment strategy and clinical outcome remain unclear. Retrospective analysis of nationwide epidemiological data shows that time for AP diagnosis has shortened, and the amount of initial fluid resuscitation has increased over time, indicating the compliance with guidelines. In contrast, prophylactic use of broad-spectrum antibiotics has emerged. Despite the potential benefits of early enteral nutrition, its use is still limited. The roles of continuous regional arterial infusion in the improvement of prognosis and the prevention of late complications are uncertain. Furthermore, early-phase treatments have had little impact on late-phase complications, such as walled-off necrosis, surgery requirements and late (> 4 w) AP-related death. Based on these observations, early-phase treatments for AP in Japan have approached the optimal level, but late-phas...Continue Reading

References

Jun 4, 2004·BMJ : British Medical Journal·Paul E Marik, Gary P Zaloga
May 31, 2006·World Journal of Gastroenterology : WJG·Makoto OtsukiUNKNOWN Research Committee of Intractable Diseases of the Pancreas
Mar 25, 2009·Journal of Gastroenterology·Takashi UedaHarumasa Ohyanagi
Jan 30, 2010·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Timothy B GardnerMichael G Sarr
Apr 23, 2010·The New England Journal of Medicine·Hjalmar C van SantvoortUNKNOWN Dutch Pancreatitis Study Group
Dec 17, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Damian J MoleRowan W Parks
Apr 19, 2011·Pancreas·Kennichi SatohUNKNOWN Research Committee of Intractable Diseases of the Pancreas
May 10, 2012·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Povilas IgnataviciusGiedrius Barauskas
Oct 27, 2012·Gut·Peter A BanksUNKNOWN Acute Pancreatitis Classification Working Group
Oct 15, 2013·World Journal of Gastroenterology : WJG·Makoto OtsukiYoshifumi Takeyama
Aug 2, 2014·Pancreas·Shin HamadaUNKNOWN Research Committee of Intractable Diseases of the Pancreas
May 15, 2015·Journal of Hepato-biliary-pancreatic Sciences·Masamichi YokoeKoichi Hirata
Aug 27, 2015·World Journal of Gastroenterology : WJG·Michal LipinskiGrazyna Rydzewska
Sep 2, 2015·The American Journal of Gastroenterology·Haq NawazGeorgios I Papachristou
Jan 19, 2016·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Janneke van GrinsvenUNKNOWN Dutch Pancreatitis Study Group
Sep 9, 2016·World Journal of Gastroenterology : WJG·Shin HamadaTooru Shimosegawa
Dec 14, 2016·The New England Journal of Medicine·Chris E ForsmarkC Mel Wilcox

❮ Previous
Next ❯

Citations

Jul 4, 2020·Current Opinion in Gastroenterology·Jorge D Machicado, Georgios I Papachristou
Mar 26, 2021·World Journal of Emergency Surgery : WJES·Massimo SartelliPierluigi Viale

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.